Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation

The New England Journal of Medicine
A G van WassenaerT Vulsma

Abstract

Premature infants who have transient hypothyroxinemia in the first weeks of life may have developmental delay and neurologic dysfunction. Whether thyroxine treatment during this period results in improved developmental outcomes is not known. We carried out a randomized, placebo-controlled, double-blind trial of thyroxine supplementation in 200 infants born at less than 30 weeks' gestation. Thyroxine (8 microg per kilogram of birth weight) or placebo was administered daily, starting 12 to 24 hours after birth, for six weeks. Plasma free thyroxine concentrations were measured weekly for the first eight weeks after birth. Scores on the Bayley Mental and Psychomotor Development Indexes and neurologic function were assessed at 6, 12, and 24 months of age (corrected for prematurity). Mortality and morbidity up to the time of discharge from the hospital were similar in the study groups. At 24 months of age, 157 infants were evaluated. Overall, neither mental nor psychomotor scores differed significantly between the study groups at any time, nor was the frequency of abnormal neurologic outcome significantly different. In thyroxine-treated infants born at gestational ages of less than 27 weeks, the score on the Bayley Mental Development...Continue Reading

References

Jun 1, 1978·The Journal of Pediatrics·R A Cuestas
Apr 1, 1979·The Journal of Pediatrics·R A Cuestas, R R Engel
Jul 31, 1992·Behavioural Brain Research·L S de VriesL M Dubowitz
Oct 1, 1988·Archives of Disease in Childhood·A LucasR Morley
Jan 1, 1989·Biology of the Neonate·P S Timiras, E U Nzekwe
Mar 1, 1988·Early Human Development·M MercadoH Gold
Jul 1, 1970·The Journal of Pediatrics·L M DubowitzC Goldberg
Sep 22, 1994·The New England Journal of Medicine·M HackN Mercuri-Minich

❮ Previous
Next ❯

Citations

Jun 23, 2000·Clinics in Perinatology·T M O'Shea, O Dammann
Jul 20, 1999·Molecular and Cellular Endocrinology·V M DarrasT J Visser
Mar 12, 2004·Seminars in Neonatology : SN·Aleid G van Wassenaer, Joke H Kok
Mar 12, 2004·Seminars in Neonatology : SN·Guy Van Vliet, Paul Czernichow
May 10, 2000·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·B J SmitJ H Kok
May 14, 1998·Clinical Endocrinology·R AchironD S Seidman
Jul 12, 2002·The New England Journal of Medicine·José C MorenoC Ris-Stalpers
Sep 29, 2001·Thyroid : Official Journal of the American Thyroid Association·D A PaulL Bartoshesky
Nov 13, 2003·Thyroid : Official Journal of the American Thyroid Association·Michelle J KantorDavid A Paul
Feb 26, 1999·Thyroid : Official Journal of the American Thyroid Association·S LaFranchi
Aug 14, 1999·Thyroid : Official Journal of the American Thyroid Association·D A Fisher
Feb 26, 1999·Thyroid : Official Journal of the American Thyroid Association·A G Van WassenaerJ J de Vijlder
Feb 11, 2010·Thyroid : Official Journal of the American Thyroid Association·Nevena SimicJoanne Rovet
Apr 29, 1999·Current Opinion in Obstetrics & Gynecology·J H Mestman
Aug 16, 2000·Current Opinion in Pediatrics·A W Root
Jun 5, 2001·Current Opinion in Pediatrics·H Kirpalani, E Asztalos
May 1, 2002·Current Opinion in Pediatrics·JoAnn Harrold, Barbara Schmidt
Jul 20, 2002·Current Opinion in Pediatrics·Jon Oden, Michael Freemark
May 19, 2009·Current Opinion in Pediatrics·Judy L Shih, Michael S D Agus
Jan 26, 2012·Current Opinion in Pediatrics·Edmund F La Gamma, Nigel Paneth
Sep 23, 2003·Archives of Disease in Childhood·M J K de KleineS P Verloove-Vanhorick
Nov 10, 2001·Annual Review of Genomics and Human Genetics·H L Levy, S Albers
Feb 11, 2005·Biology of the Neonate·Camilia R MartinUNKNOWN Developmental Epidemiology Network
Mar 2, 2006·Biology of the Neonate·Luca FilippiSalvatore Seminara
Feb 8, 2006·BMC Pediatrics·David A PaulJohn L Stefano
Nov 14, 1997·Pediatric Research·A G van WassenaerJ J de Vijlder
Feb 9, 2012·Journal of Pediatric Endocrinology & Metabolism : JPEM·Susana AresGabriella Morreale de Escobar
Nov 17, 2006·Treatments in Endocrinology·Edmund F La GammaDelbert Fisher
Apr 9, 2002·Journal of Endocrinological Investigation·J Bernal
Mar 24, 2011·Journal of Endocrinological Investigation·A MarsiliP R Larsen
Apr 2, 2014·Thyroid : Official Journal of the American Thyroid Association·Aleid van Wassenaer-LeemhuisEdmund F LaGamma
Nov 14, 1997·American Journal of Public Health·M L ReussM Susser
Aug 22, 2000·Archives of Disease in Childhood. Fetal and Neonatal Edition·J RogahnL Amegavie
Sep 27, 2014·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Sze M NgA Michael Weindling
Dec 18, 2013·Seminars in Pediatric Surgery·Ari J Wassner, Biren P Modi
Oct 11, 2011·Pediatric Clinics of North America·Sharon J HymanIan Holzman
Feb 5, 2011·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·C GoissenP Tourneux
Jul 14, 2010·Journal of Pediatric Surgery·Jill S WhitehouseMarjorie J Arca

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.